Characterization of JNJ-80948543 a novel CD79bxCD20xCD3 trispecific antibody for B-cell non-Hodgkin lymphoma

Despite advances in targeted therapies, relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL) remains incurable in the majority of patients. Thus, there is a critical need to expand the treatment options for R/R B-NHL to improve patient outcomes. In this study, we characterized JNJ-80948543,...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anna Kuchnio, Danlin Yang, Nele Vloemans, Ivo Cornelissen, Ricardo Amorim, Tatiana Perova, Cassandra Lowenstein, Lut Janssen, Toon Suls, Mariette Bekkers, Elena Lasorsa, Lorena Fontan, Neeharika Nemani, Taylor Hojnacki, Chao Han, Siddharth Sukumaran, Nicole Medeiros, Srimathi Srinivasan, Bingyuan Wu, Jun Chen, Michael D. Feldkamp, Sam Wu, Habtom Habte, Autumn J. McRee, Nikki Daskalakis, John Krayer, Cam Holland, Ricardo Attar, Phillip M. DeYoung, Sanjaya Singh, Yusri Elsayed, Ulrike Philippar
Format:	Artigo
Idioma:	Inglês
Publicat:	Ferrata Storti Foundation 2026-02-01
Col·lecció:	Haematologica
Accés en línia:	https://haematologica.org/article/view/13176
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!